Carlota
Carlota Aguilar-Long, Bayou Vista, TX US
Patent application number | Description | Published |
---|---|---|
20080199841 | Method to overcome pain and addiction - The present invention is directed to a method of treating pain and addiction in an individual. The mode of treatment is via a class, which combines 1) an alternative to reality through the simulation of real life experience, 2)discussion where individual participants a) identify factors that influenced the characters' and their choices by utilizing a behavior and self diagram, b)Evaluate the opinion of scholars and experts in the field, 3) The use of neuro-linguistic programming excercises to process emotions that have hindered the individual's life. This method provides an individual with alternative choices in life and helps develop positive goals for the future. | 08-21-2008 |
Carlota Bardina, Cerdanyola Del Valles ES
Patent application number | Description | Published |
---|---|---|
20140219968 | NOVEL SALMONELLA BACTERIOPHAGE COMPOSITIONS AND USES THEREOF - The present invention relates to novel bacteriophages and bacteriophage cocktails containing the novel bacteriophages and or parts and/or products of them, all of them belonging to the Caudovirales order. The novel bacteriophages and the bacteriophage cocktails containing the novel bacteriophages and or parts and/or products of them are | 08-07-2014 |
Carlota Vinals Bassols, Liege BE
Patent application number | Description | Published |
---|---|---|
20100204458 | Process for the Production of Immunogenic Compositions - The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3. | 08-12-2010 |
20100209444 | MAGE3 Polypeptides - The present invention relates to novel MAGE3 polypeptides, including a fragment of MAGE3 fused to an immunological fusion partner, and compositions thereof. | 08-19-2010 |
20120269835 | PROCESS FOR THE PRODUCTION OF IMMUNOGENIC COMPOSITIONS - The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3. | 10-25-2012 |
Carlota Vinals Y De Bassols, Rixensart BE
Patent application number | Description | Published |
---|---|---|
20080249013 | Vaccines - Compositions and methods for the therapy and diagnosis of cancer, particularly lung, colon, colorectal and breast cancer, are disclosed. Illustrative compositions comprise one or more Cripto tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung, colon, colorectal and breast cancer. | 10-09-2008 |
20090202577 | CASB618 Polynucleotides and Polypeptides and Their Use - CASB618 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB618 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions. | 08-13-2009 |
20100291121 | Tumour-Specific Animal Proteins - CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal, breast, and lung cancers, autoimmune diseases, and related conditions. | 11-18-2010 |
20110052615 | TUMOUR-SPECIFIC ANIMAL PROTEINS - CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions. | 03-03-2011 |
20120244175 | TUMOR SPECIFIC ANIMAL PROTEINS - CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions. | 09-27-2012 |
Carlota Vinals Y De Bassols, Brussels BE
Patent application number | Description | Published |
---|---|---|
20100143412 | BASB027 PROTEINS AND GENES FROM MORAXELLA CATARRHALIS, ANTIGENS, ANTIBODIES, AND USES - The invention provides BASB027 polypeptides and polynucleotides encoding BASB027 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses. | 06-10-2010 |